rs117747863

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_003114.5(SPAG1):​c.1542G>A​(p.Leu514Leu) variant causes a synonymous change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00359 in 1,607,124 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0031 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0036 ( 14 hom. )

Consequence

SPAG1
NM_003114.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 7.76

Publications

1 publications found
Variant links:
Genes affected
SPAG1 (HGNC:11212): (sperm associated antigen 1) The correlation of anti-sperm antibodies with cases of unexplained infertility implicates a role for these antibodies in blocking fertilization. Improved diagnosis and treatment of immunologic infertility, as well as identification of proteins for targeted contraception, are dependent on the identification and characterization of relevant sperm antigens. The protein expressed by this gene is recognized by anti-sperm agglutinating antibodies from an infertile woman. Furthermore, immunization of female rats with the recombinant human protein reduced fertility. This protein localizes to the plasma membrane of germ cells in the testis and to the post-acrosomal plasma membrane of mature spermatozoa. Recombinant polypeptide binds GTP and exhibits GTPase activity. Thus, this protein may regulate GTP signal transduction pathways involved in spermatogenesis and fertilization. Two transcript variants of this gene encode the same protein. [provided by RefSeq, Jul 2008]
SPAG1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 8-100220285-G-A is Benign according to our data. Variant chr8-100220285-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 416525.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00309 (471/152290) while in subpopulation NFE AF = 0.00447 (304/68022). AF 95% confidence interval is 0.00406. There are 2 homozygotes in GnomAd4. There are 233 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPAG1NM_003114.5 linkc.1542G>A p.Leu514Leu synonymous_variant Exon 13 of 19 ENST00000388798.7 NP_003105.2 Q07617-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPAG1ENST00000388798.7 linkc.1542G>A p.Leu514Leu synonymous_variant Exon 13 of 19 1 NM_003114.5 ENSP00000373450.3 Q07617-1
SPAG1ENST00000251809.4 linkc.1542G>A p.Leu514Leu synonymous_variant Exon 13 of 19 5 ENSP00000251809.3 Q07617-1
SPAG1ENST00000523302.1 linkn.343-4888G>A intron_variant Intron 1 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.00310
AC:
471
AN:
152172
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00763
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00447
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00284
AC:
692
AN:
243494
AF XY:
0.00273
show subpopulations
Gnomad AFR exome
AF:
0.000558
Gnomad AMR exome
AF:
0.000527
Gnomad ASJ exome
AF:
0.00135
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00725
Gnomad NFE exome
AF:
0.00414
Gnomad OTH exome
AF:
0.00101
GnomAD4 exome
AF:
0.00365
AC:
5304
AN:
1454834
Hom.:
14
Cov.:
31
AF XY:
0.00355
AC XY:
2568
AN XY:
723540
show subpopulations
African (AFR)
AF:
0.000455
AC:
15
AN:
32946
American (AMR)
AF:
0.000565
AC:
24
AN:
42502
Ashkenazi Jewish (ASJ)
AF:
0.00116
AC:
30
AN:
25756
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39646
South Asian (SAS)
AF:
0.00129
AC:
109
AN:
84556
European-Finnish (FIN)
AF:
0.00725
AC:
387
AN:
53354
Middle Eastern (MID)
AF:
0.000871
AC:
5
AN:
5738
European-Non Finnish (NFE)
AF:
0.00407
AC:
4513
AN:
1110194
Other (OTH)
AF:
0.00367
AC:
221
AN:
60142
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
239
477
716
954
1193
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00309
AC:
471
AN:
152290
Hom.:
2
Cov.:
33
AF XY:
0.00313
AC XY:
233
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.000722
AC:
30
AN:
41540
American (AMR)
AF:
0.000850
AC:
13
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
0.00763
AC:
81
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00447
AC:
304
AN:
68022
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00361
Hom.:
1
Bravo
AF:
0.00260
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00507
EpiControl
AF:
0.00397

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SPAG1: BP4, BS2 -

Primary ciliary dyskinesia Benign:1
Sep 30, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Primary ciliary dyskinesia 28 Benign:1
Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
8.5
DANN
Benign
0.81
PhyloP100
7.8
Mutation Taster
=35/65
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117747863; hg19: chr8-101232513; COSMIC: COSV52561695; API